Authors


Maged K. Rizk, MD, MBA

Latest:

Dialysis Costs for a Health System Participating in Value-Based Care

In a large, integrated health system participating in value-based care, higher costs and utilization were observed before and after unplanned dialysis initiation.


Amit Saxena, MD

Latest:

Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice

Amit Saxena, MD, discusses how personalized treatment decisions for lupus nephritis require careful consideration of patient characteristics, multidisciplinary coordination, and emerging guidelines, while acknowledging both the opportunities and challenges that lie ahead in clinical practice.


Matthias Kirch, MS

Latest:

Older Adults’ Perspectives on Emergency Department Costs During COVID-19

Most older US adults have concerns about emergency department visit affordability. Lower income, being uninsured, poor or fair physical/mental health, and younger age were associated with increased concerns.


Austin Campbell, PhD

Latest:

Identifying Chronic Kidney Disease Stage 3 With Excess Disease Burden

A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology intervention.


Ryan Cox

Latest:

Contributor: How Payers Can Be Effective in New Value-Based Models for CKD

The author discusses how value-based payment models in chronic kidney disease can improve total cost and quality of care for patienst with chronic kidney disease (CKD).


Shraddha Patel, MPH

Latest:

Hospitalization Patterns Among Older Patients With Cancer With and Without Dementia

Dementia was more prevalent in older patients with some cancer types, and comorbid dementia in this population was associated with unplanned or unnecessary hospitalization.


Kaelyn C. Boss, PharmD

Latest:

Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid Patients

Implementing a proactive provider outreach program resulted in significantly more prior authorization recertifications and a reduction in time to submission.


Jared Hirsch, MSc

Latest:

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.


Shelytia Cocroft, PhD

Latest:

Hospital Strategies in Commercial Episode-Based Reimbursement

This study reports qualitative findings from an explanatory sequential mixed-methods investigation to understand hospitals’ approaches to a novel commercial episode-based reimbursement incentive program.


Jon Kingsdale, PhD

Latest:

Successes and Failures With Bundled Payments in the Commercial Market

The relatively few examples of commercially funded condition-specific bundled payments provide insights into how to spread this alternative payment model further in the private insurance market.


Courtney R. Brown, PharmD

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Lin Jin, MB

Latest:

Current Status and Influencing Factors of Nursing Interruption Events

This study investigated the current status of nursing interruption events and analyzed the time costs, priority of events, and factors influencing interruptions.


Jack LaViolette, MSc

Latest:

Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of Color

The authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.


Katy Kaplan, PhD

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Tavajay Campbell, PharmD, BCACP

Latest:

Charitable Medication Distribution Improves Care for Uninsured Patients With Diabetes

This report illustrates how providing vital diabetes medications to uninsured patients through a charitable medication distributor improves clinical outcomes.


Sylvia Garay, MD

Latest:

Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.


Xiao Chen, PhD

Latest:

Intersection of Complexity and High Utilization Among Health Center Patients Aged 18 to 64 Years

This paper utilizes latent class analysis to identify subgroups of complex conditions and of super-utilizers among health center patients to inform clinically tailored efforts.


Yolande M. Pengetnze, MD

Latest:

Timely Preterm-Birth Prediction Among Pregnant Women in Medicaid Without Preterm-Birth History

A novel prediction model is developed that accurately predicts preterm birth in a timely manner among pregnant women in Medicaid without preterm-birth history.



Ira B. Wilson, MD, MSc

Latest:

Medicaid Expansion, Managed Care Plan Composition, and Enrollee Experience

Medicaid expansion was associated with substantial changes in Medicaid managed care plan composition, which may influence a plan’s performance on enrollee experience metrics.


Lindsay Musial, PharmD

Latest:

Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists

This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.


Katie S. Murray, DO

Latest:

Final Panel Thoughts on Uncomplicated UTI Management

Panelists discuss how the management of uncomplicated urinary tract infections (UTIs) is evolving, with promising new therapies that address antibiotic resistance concerns, while emphasizing the continued importance of antimicrobial stewardship, personalized treatment approaches, preventive strategies, and comprehensive patient education to reduce recurrence rates and improve outcomes in this common but burdensome condition.



Thomas G. Weiss, BS

Latest:

Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare Beneficiaries

Diabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.


Michelle Winkler, PhD, MPH

Latest:

Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.


Sarah R. MacEwan, PhD

Latest:

Relationships Between Patient Portal Activation and Patient Satisfaction Scores Among CG-CAHPS and HCAHPS Respondents

Patients with activated patient portal accounts report higher patient satisfaction in respective dimensions of the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) and Hospital CAHPS (HCAHPS) surveys compared with patients without portal accounts.


Akira Nishii, BS

Latest:

Patient-Centered Communication, Disparities, and Patient Portals in the US, 2017-2022

From 2017 to 2022, patients with better communication with providers were more likely to report being offered and accessing a patient portal, but disparities persist.


Victoria Johnson

Latest:

Higher Risk of ILD in Patients With RA, PsA Initiating bDMARDs

There were no differences in risk between patients with RA or PsA using or not using methotrexate.


Ruben Mesa, MD

Latest:

Management of MPN: Benchmarks For Quality Care

Ruben Mesa, MD, leads a discussion on key benchmarks and final thoughts about good-quality care programs for patients with MPNs, including parameters for judging efficacy and safety.


John Michael O’Brien, PharmD, MPH

Latest:

Understanding the Relationship Between Government Policies, Patient Access: John M. O'Brien, PharmD, MPH

Improving relationships between pharmaceutical makers, health systems, patients, and insurers can help to lower the price of health care for patients, according to John Michael O'Brien, PharmD, MPH.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo